The confidence and supply agreement between the Liberals and the NDP commits the former to taking steps to implementing a pharmacare plan by June 2025. The question is whether that will be a Québec model that preserves the profits of the drug companies and the insurance industry or a public model that puts the health of Canadians first. The choice should be obvious.

The pharmaceutical industry has remained near or at the top of the list for profitability for many decades. The myth is that its profits come from producing and selling the many therapeutic advances that industry research has generated, but the reality is far different.